Pheromone Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 M
as on 16-11-2024
- Company Age 35 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.00 M
as on 16-11-2024
- Revenue -13.73%
(FY 2023)
- Profit 128.93%
(FY 2023)
- Ebitda 248.11%
(FY 2023)
- Net Worth 42.20%
(FY 2023)
- Total Assets -34.63%
(FY 2023)
About Pheromone Chemicals
The Corporate was formerly known as Miraj Investments Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.70 Cr. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dhara Sanket, Sangita Gandhi, and Sanket Gandhi serve as directors at the Company.
- CIN/LLPIN
U51101GJ1989PTC013075
- Company No.
013075
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pheromone Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhara Sanket  | Director | 05-Sep-2014 | Current |
| Sangita Gandhi | Director | 15-Aug-2009 | Current |
| Sanket Gandhi | Director | 06-Feb-2009 | Current |
Financial Performance of Pheromone Chemicals.
Pheromone Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.73% decrease. The company also saw a substantial improvement in profitability, with a 128.93% increase in profit. The company's net worth Soared by an impressive increase of 42.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pheromone Chemicals?
In 2022, Pheromone Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Feb 2023 | ₹6.59 M | Open |
Axis Bank Limited Creation Date: 07 Dec 2021 | ₹1.04 Cr | Open |
Central Bank Of India Creation Date: 17 Jun 2005 | ₹2.00 M | Satisfied |
How Many Employees Work at Pheromone Chemicals?
Unlock and access historical data on people associated with Pheromone Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pheromone Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pheromone Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
